Skip to main content
An official website of the United States government

monoclonal antibody GIM-122

A humanized immunoglobulin G1 kappa (IgG1K) dual-functioning monoclonal antibody, with potential immunomodulating and antineoplastic activities. Upon administration, monoclonal antibody GIM-122 targets and binds to as of yet unidentified molecules on target cells and may modulate the immune system and reduce tumor cell proliferation.
Check for active clinical trials using this agentView this agent in the NCI Thesaurus
Code name:GIM 122
GIM-122
GIM122
Search NCI's Drug Dictionary
Please enter up to 30 characters for your search